Consumer Driven Health Care

Underscoring these concerns, nearly half of insured adults (46%) say that lowering out-of-pocket costs is the change they'd most like to see to their health insurance.

CenterWell Pharmacy (a part of Humana Inc.) announced plans to develop end-to-end employer prescription solutions with Cost Plus Drugs.

Pharmaceutical Strategies Group survey finds employers and health plans prioritizing cost control and cross-benefit management, with growing willingness to trade rebates for stronger utilization oversight amid rising complexity and CGT concerns.

Capital Blue Cross is partnering with the Mark Cuban Cost Plus Drug Co. to make lower‑cost biosimilar alternatives to Humira and Stelara available to commercial members.

Physicians warn rapid adoption is outpacing oversight, urging transparency, crisis protections and clearer rules as demand grows amid persistent gaps in care.

The new program seeks to connect GLP-1 management with primary care and Amazon Pharmacy in one place, according to the company.